Rare diseases
Investigational molecules
Locations
Back to Germany46 clinical trials in Nuertingen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on metastatic castration-resistant prostate cancer (mCRPC) and innovative combination therapies. Current trials are evaluating novel treatment approaches including targeted therapies and hormone-based interventions.
Multiple studies are investigating treatments for both early-stage and advanced disease states, with particular emphasis on improving survival rates.
Comprehensive research into non-muscle invasive bladder cancer treatments, including novel immunotherapy combinations and targeted therapeutic approaches.
Studies are evaluating both standard and experimental treatments to improve patient outcomes and reduce recurrence rates.
Innovative research utilizing biomarker-driven treatment strategies and personalized medicine approaches for urological cancers.
Focus on developing treatments tailored to specific genetic profiles and disease characteristics.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
